Evaluation of Procalcitonin’s Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients
Article
[키워드] Antibiotic therapy
AUC
Bacteremia
Bacterial
Bacterial infection
bacterial pneumonia
baseline characteristics
Concomitant
conducted
COVID-19
creatinine
Critical
Critical illness
Critically ill patient
Culture
defined
determine
diagnosing
diagnostic
ENhance
evaluate
group
hospitalized patients
ICU
ICU patient
identify
Ill
in-hospital mortality
intensive care
intensive care unit
Mortality
multivariable
multivariable model
no difference
no significant difference
offer
outcome
Patient
PCT
Pneumonia
positive
predict
Predictive
procalcitonin
receiver operating characteristics
Regression model
retrospective cohort study
ROC
SARS-CoV-2
secondary bacterial pneumonia
serum creatinine
Severe COVID-19 pneumonia
Severity of disease
specificity
threshold
utility
variable
vital signs
was used
while
with COVID-19
[DOI] 10.1177/08850666221108636 PMC 바로가기
[DOI] 10.1177/08850666221108636 PMC 바로가기